nach oben

Erschienen in:

22.02.2019 | Letter to the Editor

Synovial fluid as an alternative specimen for quantification of drugs of abuse by GC–MS

verfasst von: Evangelia Petrochilou, Sotiris Athanaselis, Panagiota Nikolaou, Stavroula Papadodima, Irene Panderi, Chara Spiliopoulou, Ioannis Papoutsis

Erschienen in: Forensic Toxicology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

United Nations Office on Drugs and Crime (2018) World drug report 2018. United Nations publication, Vienna. https://unodc.org/wdr2018. Accessed 28 Dec 2018

European Monitoring Centre for Drugs and Drug Addiction (2018) European drug report 2018: Trends and developments. Publications Office of the European Union, Luxembourg. https://doi.org/10.2810/800331 CrossRef

Dinis-Oliveira RJ, Vieira DN, Magalhães T (2016) Guidelines for collection of biological samples for clinical and forensic toxicological analysis. Forensic Sci Res 1:42–51. https://doi.org/10.1080/20961790.2016.1271098 CrossRefPubMed

Griffiths JL (2012) An investigation of the use of alternative matrices in clinical and forensic toxicology. Thesis, University of Birmingham. http://etheses.bham.ac.uk/4017/1/Griffiths13MPhil.pdf. Accessed 28 Nov 2018

TIAFT Committee of Systematic Toxicological Analysis (2011) Recommendations on sample preparation of biological specimens for systematic toxicological analysis. TIAFT Bull XLI(2):30–34. https://www.tiaft.org/data/uploads/documents/tiaft-sta-recommendations-on-sample-preparation.pdf. Accessed 28 Nov 2018

Kadehjian LJ (2005) Specimens for drugs-of-abuse testing. In: Wong RC, Tse HY (eds) Drugs of abuse: body fluid testing. Humana Press, New York City, pp 11–28CrossRef

Gallardo E, Queiroz JA (2008) The role of alternative specimens in toxicological analysis. Biomed Chromatogr 22:795–821CrossRefPubMed

DeKing J, Hargrove VM, Molina DK (2014) Synovial fluid: an alternative toxicologic specimen? Am J Forensic Med Pathol 35:154–156CrossRefPubMed

Jenkins AJ (2008) Drug testing in alternate biological specimens. Humana Press, New York CityCrossRef

10.

Hui AY, McCarty WJ, Masuda K, Firestein GV, Sah RL (2012) A systems biology approach to synovial joint lubrication in health, injury, and disease. Wiley Interdiscip Rev Syst Biol Med 4:15–37CrossRefPubMed

11.

Šita F, Křížala J, Dítě P, Krupař V (1971) Nachweis einiger Heilmittel in der Kniegelenksynovialflüssigkeit. Arch Toxikol 27:242–247 (in German with English abstract) CrossRefPubMed

12.

Andresen H, Schmoldt H, Matschke J, Flachskampf FA, Turk EE (2008) Fatal methanol intoxication with different survival times–morphological findings and postmortem methanol distribution. Forensic Sci Int 179:206–210CrossRefPubMed

13.

Kugelberg FC, Jones AW (2007) Interpreting results of ethanol analysis in postmortem specimens: a review of the literature. Forensic Sci Int 165:10–29CrossRefPubMed

14.

Day RO, McLachlan AJ, Graham GG, Williams KM (1999) Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 36:191–210CrossRefPubMed

15.

Rees KA, McLaughlin PA, Osselton MD (2012) Validation of a gas chromatography-ion trap-tandem mass spectrometry assay for the simultaneous quantification of cocaine, benzoylecgonine, cocaethylene, morphine, codeine, and 6-acetylmorphine in aqueous solution, blood, and skeletal muscle tissue. J Anal Toxicol 36:1–11CrossRefPubMed

16.

Antonides HM, Kiely ER, Marinetti LJ (2007) Vitreous fluid quantification of opiates, cocaine, and benzoylecgonine: comparison of calibration curves in both blood and vitreous matrices with corresponding concentrations in blood. J Anal Toxicol 31:469–476CrossRefPubMed

17.

Lerch O, Temme O, Daldrup T (2014) Comprehensive automation of the solid phase extraction gas chromatographic mass spectrometric analysis (SPE-GC/MS) of opioids, cocaine, and metabolites from serum and other matrices. Anal Bioanal Chem 406:4443–4451CrossRefPubMedPubMedCentral

18.

Concheiro M, Castro A, Quintela O, Lopez-Rivadulla M, Cruz A (2006) Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities. J Chromatogr B 832:81–89CrossRef

19.

Pedersen AJ, Dalsgaard PW, Rode AJ, Rasmussen BS, Muller IB, Johansen SS, Linnet K (2013) Screening for illicit and medicinal drugs in whole blood using fully automated SPE and ultra-high-performance liquid chromatography with TOF-MS with data-independent acquisition. J Sep Sci 36:2081–2089CrossRefPubMed

20.

Bjork MK, Nielsen MKK, Markussen LO, Klinke HB, Linnet K (2010) Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 396:2393–2401CrossRefPubMed

21.

Segi M, Bafile E, Compagnone D, Curini R, D’Ascenzo G, Romolo FS (2009) Multiclass analysis of illicit drugs in plasma and oral fluids by LC–MS/MS. Anal Bioanal Chem 393:709–718CrossRef

22.

Brikler RID, Telving R, Ingemann-Hansen O, Charles AV, Johannsen M, Andreasen MF (2012) Screening analysis for medicinal drugs and drugs of abuse in whole blood using ultra-performance liquid chromatography time-of-flight mass spectrometry (UPLC-TOF-MS)—toxicological findings in cases of alleged sexual assault. Forensic Sci Int 222:154–161CrossRef

23.

Dowling G, Regan L (2011) A new mixed mode solid phase extraction strategy for opioids, cocaines, amphetamines and adulterants in human blood with hybrid liquid chromatography tandem mass spectrometry detection. J Pharm Biomed Anal 54:1136–1145CrossRefPubMed

24.

Fernandez MMR, Wille SM, Kummer N, Di Fazio V, Ruyssinckx E, Samyn N (2013) Quantitative analysis of 26 opioids, cocaine, and their metabolites in human blood by ultra-performance liquid chromatography–tandem mass spectrometry. Ther Drug Monit 35:510–521CrossRef

25.

Ruiz-Colón K, Martínez MA, Silva-Torres LA, Chavez-Arias C, Meléndez-Negrón M, Conte-Miller MS, Bloom-Oquendo J (2012) Simultaneous determination of xylazine, free morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in postmortem blood by UPLC-MS-MS. J Anal Toxicol 36:319–326CrossRefPubMed

26.

Øiestad EL, Johansen U, Øiestad AML, Christophersen AS (2011) Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 35:280–293CrossRefPubMed

27.

Vindenes V, Lund HME, Andresen W, Gjerde H, Ikdahl SE, Christophersen AS, Øiestad EL (2012) Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Forensic Sci Int 219:165–171CrossRefPubMed

28.

Li X, Shen B, Jiang Z, Huang Y, Zhuo X (2013) Rapid screening of drugs of abuse in human urine by high-performance liquid chromatography coupled with high resolution and high mass accuracy hybrid linear ion trap-Orbitrap mass spectrometry. J Chromatogr A 1302:95–104CrossRefPubMed

29.

Schaefer N, Peters B, Schmidt P, Ewald AH (2013) Development and validation of two LC-MS/MS methods for the detection and quantification of amphetamines, designer amphetamines, benzoylecgonine, benzodiazepines, opiates, and opioids in urine using turbulent flow chromatography. Anal Bioanal Chem 405:247–258CrossRefPubMed

30.

Berg T, Lundanes E, Christophersen AS, Strand DH (2009) Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC–MS/MS. J Chromatogr B 877:421–432CrossRef

31.

Concheiro M, De Castro A, Quintela O, Cruz A, López-Rivadulla M (2007) Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion. J Anal Toxicol 31:573–580CrossRefPubMed

32.

Dowling G, Regan L, Tierney J, Nangle M (2010) A hybrid liquid chromatography-mass spectrometry strategy in a forensic laboratory for opioid, cocaine and amphetamine classes in human urine using a hybrid linear ion trap-triple quadrupole mass spectrometer. J Chromatogr A 1217:6857–6866CrossRefPubMed

33.

Guale F, Shahreza S, Walterscheid JP, Chen HH, Arndt C, Kelly AT, Mozayani A (2013) Validation of LC–TOF–MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens. J Anal Toxicol 37:17–24CrossRefPubMed

34.

Fernández MMR, Van Durme F, Wille SMR, Di Fazio V, Kummer N, Samyn N (2014) Validation of an automated solid-phase extraction method for the analysis of 23 opioids, cocaine, and metabolites in urine with ultra-performance liquid chromatography-tandem mass spectrometry. J Anal Toxicol 38:280–288CrossRef

35.

Antelo-Domínguez A, Cocho JÁ, Tabernero MJ, Bermejo AM, Bermejo-Barrera P, Moreda-Piñeiro A (2013) Simultaneous determination of cocaine and opiates in dried blood spots by electrospray ionization tandem mass spectrometry. Talanta 117:235–241CrossRefPubMed

36.

Saussereau E, Lacroix C, Gaulier JM, Goulle JP (2012) On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots. J Chromatogr B 885–886:1–7CrossRef

37.

Orfanidis A, Mastrogianni O, Koukou A, Psarros G, Gika H, Theodoridis G, Raikos N (2016) A GC–MS method for the detection and quantitation of ten major drugs of abuse in human hair samples. J Chromatogr B 1047:141–150CrossRef

38.

Gouveia CA, Oliveira A, Pinho S, Vasconcelos C, Carvalho F, Moreira RF, Dinis-Oliveira RJ (2012) Simultaneous quantification of morphine and cocaine in hair samples from drug addicts by GC–EI/MS. Biomed Chromatogr 26:1041–1047CrossRefPubMed

39.

Peres MD, Pelicao FS, Caleffi B, De Martinis BS (2014) Simultaneous quantification of cocaine, amphetamines, opiates and cannabinoids in vitreous humor. J Anal Toxicol 38:39–45CrossRefPubMed

40.

Contreras MT, Hernández AF, González M, González S, Ventura R, Pla A, Valverde JL, Segura J, de la Torre R (2006) Application of pericardial fluid to the analysis of morphine (heroin) and cocaine in forensic toxicology. Forensic Sci Int 164:168–171CrossRefPubMed

41.

Courtney P, Doherty M (2013) Joint aspiration and injection and synovial fluid analysis. Best Pract Res Clin Rheumatol 27:137–169CrossRefPubMed

42.

Alshammari TM, Al-Hassan AA, Hadda TB, Aljofan M (2015) Comparison of different serum sample extraction methods and their suitability for mass spectrometry analysis. Saudi Pharm J 23:689–697CrossRefPubMedPubMedCentral

43.

U.S. Food and Drug Administration (FDA) (2018) Guidance for industry, bioanalytical method validation. https://www.fda.gov/downloads/drugs/guidances/ucm070107.Pdf. Accessed 28 Sep 2018

44.

International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005) ICH harmonized tripartite guideline: validation of analytical procedures: text and methodology Q2(R1), current step 4 version. ICH, Geneva. https://ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1_Guideline.pdf. Accessed 28 Nov 2018

45.

Magnusson B, Örnemark U (eds) (2014) Eurachem guide: the fitness for purpose of analytical methods—a laboratory guide to method validation and related topics, 2nd edn. EURACHEM, Torino. https://www.eurachem.org/images/stories/Guide/pdf/MV_guide_2nd_ed_EN.pdf. Accessed 28 Nov 2018

Titel: Synovial fluid as an alternative specimen for quantification of drugs of abuse by GC–MS
verfasst von: Evangelia Petrochilou
Sotiris Athanaselis
Panagiota Nikolaou
Stavroula Papadodima
Irene Panderi
Chara Spiliopoulou
Ioannis Papoutsis
Publikationsdatum: 22.02.2019
Verlag: Springer Singapore
Erschienen in: Forensic Toxicology / Ausgabe 2/2019
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI: https://doi.org/10.1007/s11419-019-00465-2

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Synovial fluid as an alternative specimen for quantification of drugs of abuse by GC–MS

Excerpt

Neu im Fachgebiet Rechtsmedizin

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Cytotoxicity of the synthetic cannabinoids 5C-AKB48, 5F-MDMB-PINACA, ADB-CHMINACA, MDMB-CHMICA and NM-2201 in A549 and TR146 cell lines

A pilot study of non-targeted screening for stimulant misuse using high-resolution mass spectrometry

Norcarfentanil: carfentanil misuse or remifentanil treatment?

Determination of ocfentanil and W-18 in a suspicious heroin-like powder in Belgium

Strong evidence of drug-facilitated crimes by hair analysis using LC–MS/MS after micro-segmentation

New-generation azaindole-adamantyl-derived synthetic cannabinoids

Neu im Fachgebiet Rechtsmedizin

Assistierter Suizid durch Infusion von Thiopental

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren